Results 221 to 230 of about 57,355 (265)
Some of the next articles are maybe not open access.
Extraosseous Multiple Myeloma Simulating Primary Prostatic Neoplasm
Journal of Urology, 1978The first case of multiple meyloma presenting clinically with extraskeletal prostatic involvement simulating a primary prostatic neoplasm is reported. The clinical course, pathology, and serum and urine protein findings are discussed.
openaire +3 more sources
Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms
Arkhiv patologii, 2016Prostate cancer is one of the most frequently detected malignancies in men. The gold standard for its diagnosis is morphological examination; at the same time the differential diagnosis of adenocarcinoma, high-grade prostatic intraepithelial neoplasia (HGPIN), and benign conditions that are able to mimic the malignancies is tremendously difficult in a ...
G A Frank +4 more
openaire +2 more sources
Expression and implication of hypoxia inducible factor-1α in prostate neoplasm
Current Medical Science, 2004To study the expression of hypoxia inducible factor-1alpha (HIF-1alpha) protein in prostate cancer (Pca) and its biological significance, the expression of HIF-1alpha was assayed by means of immunohistochemical technique in 42 prostate cancer, 12 prostatic intraepithelial neoplasm (PIN) and 9 normal prostate tissue (NP) specimens. Western blot was used
Ping Hao +5 more
openaire +3 more sources
Increased Serum Prolactin Pituitary Reserve in Patients with Prostatic Neoplasms
British Journal of Urology, 1979Prolactin (PRL) pituitary reserve was measured in 8 patients with prostatic adenoma and 11 patients with prostatic carcinoma. The PRL reserve was significantly higher in these patients compared to an age-matched control group of 6 subjects. A possible role for PRL-inhibiting drugs in the management of oestrogen-resistant carcinomas of the prostate is ...
G. Martorana +5 more
openaire +3 more sources
Urologic Neoplasms: Prostate, Bladder, and Renal Cell Carcinoma
2016This chapter illustrates clinical case examples demonstrating clinical utility and diagnostic performance of FDG PET-CT scans in prostate, bladder, and renal cell carcinoma.
Hossein Jadvar, Bhushan Desai
openaire +2 more sources
Prostate Marker Immunoreactivity in Salivary Gland Neoplasms
The American Journal of Surgical Pathology, 1993A 66-year-old man presented with a mass just behind the lower part of the left ear. A biopsy showed a moderately differentiated adenocarcinoma that was prostate-specific antigen (PSA)- and prostate-specific acid phosphatase (PSAP)-positive. This finding suggested a metastasis of a prostatic carcinoma.
openaire +2 more sources
Observations on RNA in Prostate and Bladder Neoplasms
Journal of Urology, 1969Marian P. Butler +3 more
openaire +3 more sources
IMMUNOHISTOLOGICAL DEMONSTRATION OF PROSTATIC ORIGIN OF MALIGNANT NEOPLASMS
The Lancet, 1979Azorides R. Morales +3 more
openaire +3 more sources
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Neoplasms of the bladder, prostate, and urethra
Seminars in Roentgenology, 1983openaire +2 more sources